March 13, 2018 / 11:13 AM / 5 months ago

BRIEF-Optinose Reports Q4 Loss Per Share $0.64

March 13 (Reuters) - Optinose Inc:

* OPTINOSE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS

* Q4 LOSS PER SHARE $0.64

* Q4 EARNINGS PER SHARE VIEW $-0.50 — THOMSON REUTERS I/B/E/S

* EXPECTS TO INITIATE A PHASE 3B TRIAL OF XHANCE AS A TREATMENT FOR CHRONIC SINUSITIS IN Q4 OF 2018

* OPTINOSE - BELIEVES CURRENT CASH, CASH EQUIVALENTS SUFFICIENT TO FUND OPERATIONS AND DEBT SERVICE OBLIGATIONS THROUGH END OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below